I'rom Group Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares I'rom Group Co Ltd with three other
pharmaceutical manufacturers in Asia:
Neuland Laboratories Limited
sales of 5.27 billion Indian Rupees [US$75.95 million]
Wooridul Pharmaceutical Limited
of South Korea
(89.10 billion Korean Won [US$78.68 million]
of which 89%
was Finished Goods Revenues), and
Caplin Point Laboratories Limited
based in India
(5.40 billion Indian Rupees [US$77.74 million]
of which 100%
During the year ended March of 2018, sales at
I'rom Group Co Ltd were ¥8.62 billion (US$76.90 million).
increase of 76.3%
versus 2017, when the company's sales were ¥4.89 billion.
Sales of Smo Business saw an increase
74.2% in 2018, from
¥3.61 billion to ¥6.29 billion.
Not all segments of I'rom Group Co Ltd experienced an increase in sales in 2018:
sales of Other Businesses fell 14.3% to ¥12.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).